Delivery Order SPE2DB22D3102-SPE2DB24FL0YE
Award Date 4/25/24
Potential Completion Date 4/26/24
Potential Value $2K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a $38,380.44 firm fixed-price delivery order to AmerisourceBergen Drug Corporation's Corporate Office division for the supply of RotaTeq vaccine (2 mL). This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and...
- This is a federal delivery order award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $3,304.60 firm fixed price contract is for the supply of the RotaTeq vaccine, a 2ml dose product. The order has a period of performance through May 10, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several large indefinite delivery contracts (IDCs) with the DLA and Department of Justice to provide a wide range...
- This $2,605.24 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of 4,565,164,820 units of the ROTATEQ vaccine. The order has a completion date of July 17, 2024 and is not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of the parent company Cencora, Inc. The contract, valued at $5,147.40, is for the delivery of the RotaTeq vaccine, a 2-milliliter dose. The contract has a period of performance that runs through December 5, 2023. This is a firm fixed-price contract, and there is no set-aside designation indicated. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,589.60 firm fixed-price contract is for the supply of the RotaTeq vaccine, a critical medical product used for the prevention of rotavirus infections. The contract has a ceiling value of $20,589.60 and a completion date of June 8, 2023. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,576.59 Firm Fixed Price Delivery Order is for the supply of RotaTeq vaccine, a prescription medication, with a completion date of May 8, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00...
- The Defense Logistics Agency awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the ROTATEQ VACCINE 2ML. The $17,070.82 order has a completion date of March 6, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This order is issued under an indefinite delivery contract (IDC) that Amerisourcebergen Drug Corp holds with DLA, which has a potential value of up...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $5,327.90 for RotaTeq Vaccine 2ML on July 23, 2025, with an ultimate completion date of July 24, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is performed at the company's corporate office location in Conshohocken, PA. The award is funded by the Medical Supply Chain within the Defense logistics structure, supporting federal medical procurement needs. This delivery order...
- This federal contract award is for the delivery of the ROTATEQ vaccine in 2mL increments, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $2,741.22, has a completion date of February 12, 2025. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that specializes in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the vaccine RotaTeq in 2 milliliter vials. The $2,120.72 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, and has an ultimate completion date of July 3, 2024. Amerisourcebergen Drug Corp holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to...